GİZEM KARKIN TOZLU, İPEK BOZKURT, SERDAR KULA
Gazi Medical Journal - 2025;36(2):204-207
OBJECTIVE The aim was to examine the increase in the rate of respiratory syncytial virus (RSV) prophylaxis through a clinical decision support system (CDSS) added to the hospital information management system (HIS) and to determine the rate of increase before and after CDSS. METHODS In October 2023, a CDSS was defined in HIS following the RSV prophylaxis indication protocol. To measure the effect of CDSS, and to determine the patients who need to receive RSV prophylaxis between 2021 and 2024, the drug reports registered on HIS were analyzed retrospectively with the code “B97.4- RSV, the causative agent of diseases classified in other sections,” while the number of patients who started prophylaxis was recorded throughout three consecutive seasons. RESULTS Thirty-one patients between 2021-2022, 42 patients between 2022-2023 and 68 patients between 2023-2024 were immunized by issuing a report for RSV prophylaxis. According to these data, while there was a 35% increase in the prophylaxis rate before CDSS compared to the previous season, after CDSS, there was an increase to 61%. CONCLUSION Systemic alerts added to hospital systems create significant differences in the treatment and follow-up of patients, considering the busy workload of healthcare professionals.
